Barclays Raises Hims & Hers Target After Novo Deal Clears
Barclays boosts its target on Hims & Hers Health as Novo Nordisk deal removes a key legal overhang, while Progyny see...
Uncover effective strategies to find cash for bills quickly. Ensure you have the funds needed to cover essential expenses.
24,104 articlesBarclays boosts its target on Hims & Hers Health as Novo Nordisk deal removes a key legal overhang, while Progyny see...
Nebius inked a $27 billion AI infrastructure deal with Meta, locking in vast capacity and signaling its edge in the n...
Oil jumped sharply in March 2026, but USOI investors faced capped upside and ongoing credit risk. The piece explains ...
IBM’s leadership points to a quicker, clearer regulatory path for mergers and acquisitions, citing the Confluent purc...
Coinbase soared about 12% in trading after Sen. Lummis announced a bipartisan deal on the Clarity Act for stablecoin ...
Circle announces a $222 million Arc token presale at a $3 billion FDV, drawing major investors as quarterly revenue g...
As Ethereum price shows volatility, SharpLink highlights growing structural indicators of long-term institutional ado...
Ondas stock moved sharply higher after a strong Q1 revenue beat and higher full-year guidance. This piece breaks down...
NextEra Energy announces a $67 billion all-stock deal to buy Dominion Energy, a move that could kick off a broader wa...
Eli Lilly kicked off 2026 with blockbuster sales and higher guidance, reigniting talk of a path to $1800 for Lilly st...
Stocks hover near record levels while consumer sentiment sinks to multi-decade lows. This piece examines trump’s bull...
An Ouster director recently disclosed an open-market sale of thousands of shares. This deep dive explains what such m...